Medicine
Cephalexin 250 mg/5 mL powder for oral suspension
Cephalexin 250 mg/5 mL powder for oral suspension is a generic prescription medicine for oral use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 o to 25 • C (68 o to 77 • F). After mixing, store in refrigerator.
Key facts
- Active ingredient (INN)
- Cephalexin
- Brand
- Sold under the generic name
- Strength
- 250 mg/5 mL
- Dosage form
- Powder for oral suspension
- Route
- Oral
- Packs
- 200 mL, 100 mL and 32 more
- Manufacturers
- Ascend LaboratoriesIndiaAurobindo PharmaIndiaLupinIndiaBryant Ranch PrepackA-S Medication SolutionsNuCare Pharmaceuticals,IncPreferred PharmaceuticalsProficient RxChartwell RXTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20 o to 25 • C (68 o to 77 • F). After mixing, store in refrigerator.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DB01 Cephalexin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 September 1990
- Identifiers
- RxCUI 309110, 309113DailyMed set ID 655f38e8-1c4d-4cbc-9f52-bb881f065b2d, e186afb5-7531-45ea-b785-c230483a7747, f1439d25-3d3d-4fe5-b6e7-d76e62892969 +23NDC 59651-323, 63629-9207, 72162-1851 +23Application ANDA213568, ANDA210221, ANDA065234 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 200 mL in 1 bottle | 67877-545-68 | Ascend LaboratoriesIndia | 28 March 2019 |
| 100 mL in 1 bottle | 67877-545-88 | Ascend LaboratoriesIndia | 28 March 2019 |
| 100 mL in 1 bottle | 59651-323-01 | Aurobindo PharmaIndia | 9 June 2026 |
| 200 mL in 1 bottle | 59651-323-02 | Aurobindo PharmaIndia | 9 June 2026 |
| 100 mL in 1 bottle | 68180-441-01 | LupinIndia | 29 September 2017 |
| 200 mL in 1 bottle | 68180-441-02 | LupinIndia | 6 September 2017 |
| 100 mL in 1 bottle | 62135-481-42 | Chartwell RX | 1 February 2022 |
| 200 mL in 1 bottle | 62135-481-49 | Chartwell RX | 1 February 2022 |
| 100 mL in 1 bottle | 0093-4177-73 | Teva Pharmaceuticals | 30 September 1990 |
| 200 mL in 1 bottle | 0093-4177-74 | Teva Pharmaceuticals | 30 September 1990 |
| 100 mL in 1 bottle | 63629-8857-1 | Bryant Ranch Prepack | 28 March 2019 |
| 200 mL in 1 bottle | 63629-8858-1 | Bryant Ranch Prepack | 28 March 2019 |
| 100 mL in 1 bottle | 63629-9206-1 | Bryant Ranch Prepack | 28 March 2019 |
| 200 mL in 1 bottle | 63629-9207-1 | Bryant Ranch Prepack | 28 March 2019 |
| 100 mL in 1 bottle | 71335-2734-1 | Bryant Ranch Prepack | 29 July 2025 |
| 200 mL in 1 bottle | 71335-2877-1 | Bryant Ranch Prepack | 7 November 2025 |
| 100 mL in 1 bottle | 71335-2986-1 | Bryant Ranch Prepack | 10 November 2025 |
| 100 mL in 1 bottle | 72162-1851-1 | Bryant Ranch Prepack | 8 March 2024 |
| 200 mL in 1 bottle | 72162-1851-2 | Bryant Ranch Prepack | 8 March 2024 |
| 200 mL in 1 bottle | 72162-1851-4 | Bryant Ranch Prepack | 8 March 2024 |
| 200 mL in 1 bottle | 50090-4795-0 | A-S Medication Solutions | 12 December 2019 |
| 100 mL in 1 bottle | 50090-5196-0 | A-S Medication Solutions | 30 September 2020 |
| 100 mL in 1 bottle | 50090-6445-0 | A-S Medication Solutions | 20 April 2023 |
| 200 mL in 1 bottle | 50090-7091-0 | A-S Medication Solutions | 12 February 2024 |
| 100 mL in 1 bottle | 66267-982-00 | NuCare Pharmaceuticals,Inc | 18 July 2017 |
| 200 mL in 1 bottle | 68071-2889-2 | NuCare Pharmaceuticals,Inc | 23 November 2022 |
| 200 mL in 1 bottle | 68071-3587-2 | NuCare Pharmaceuticals,Inc | 20 March 2024 |
| 100 mL in 1 bottle | 68071-5038-0 | NuCare Pharmaceuticals,Inc | 21 August 2019 |
| 100 mL in 1 bottle | 68788-7529-1 | Preferred Pharmaceuticals | 4 October 2019 |
| 200 mL in 1 bottle | 68788-7529-2 | Preferred Pharmaceuticals | 4 October 2019 |
| 200 mL in 1 bottle | 68788-8686-2 | Preferred Pharmaceuticals | 3 June 2024 |
| 100 mL in 1 bottle | 63187-205-00 | Proficient Rx | 3 November 2014 |
| 200 mL in 1 bottle | 63187-205-20 | Proficient Rx | 3 November 2014 |
| 100 mL in 1 bottle | 71205-553-00 | Proficient Rx | 7 April 2021 |
| 100 mL in 1 bottle | 70518-4511-0 | Remedyrepack | 28 October 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 4 January 1971 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cephalexin
Clinical summary
Cephalexin is a cephalosporin antibacterial indicated for the treatment of infections when caused by susceptible strains of the designated microorganisms. It is available as capsules, powder for oral suspension and tablets. MedsAcross supplies Cephalexin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CephalexinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cephalexin prescribing information (Ascend Laboratories) · U.S. National Library of Medicine, DailyMed
Need Cephalexin 250 mg/5 mL powder for oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.